YU15599A - Intermedijari i proces za dobijanje olanzapina - Google Patents

Intermedijari i proces za dobijanje olanzapina

Info

Publication number
YU15599A
YU15599A YU15599A YU15599A YU15599A YU 15599 A YU15599 A YU 15599A YU 15599 A YU15599 A YU 15599A YU 15599 A YU15599 A YU 15599A YU 15599 A YU15599 A YU 15599A
Authority
YU
Yugoslavia
Prior art keywords
intermediates
preparing olanzapine
olanzapine
preparing
provides
Prior art date
Application number
YU15599A
Other languages
English (en)
Inventor
Charles Arthur Bunnel
Samuel Dean Larsen
John Richard Nichols
Susan Marie Reutzel
Gregory Alan Stephenson
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU15599(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of YU15599A publication Critical patent/YU15599A/sh
Publication of RS49598B publication Critical patent/RS49598B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Ovaj pronalazak nudi postupak za dobijanje olanzapina i intermedijara za to.[The present invention provides a process for preparing olanzapine and intermediates therefor.
YUP-155/99A 1996-09-23 1997-09-18 Intermedijari i proces za dobijanje olanzapina RS49598B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23

Publications (2)

Publication Number Publication Date
YU15599A true YU15599A (sh) 2001-12-26
RS49598B RS49598B (sr) 2007-06-04

Family

ID=21832120

Country Status (35)

Country Link
US (1) US6020487A (sh)
EP (1) EP0831098B1 (sh)
JP (2) JP2001500877A (sh)
KR (1) KR100560015B1 (sh)
CN (1) CN1122036C (sh)
AR (1) AR013838A1 (sh)
AT (1) ATE209208T1 (sh)
AU (1) AU719441B2 (sh)
BR (1) BR9712100A (sh)
CA (1) CA2265712C (sh)
CO (1) CO4910140A1 (sh)
CZ (1) CZ299248B6 (sh)
DE (1) DE69708428T2 (sh)
DK (1) DK0831098T3 (sh)
EA (1) EA001642B1 (sh)
EG (1) EG23861A (sh)
ES (1) ES2166051T3 (sh)
HU (1) HU226484B1 (sh)
ID (1) ID27275A (sh)
IL (1) IL128962A (sh)
IN (1) IN187156B (sh)
MY (1) MY125565A (sh)
NO (1) NO323980B1 (sh)
NZ (1) NZ334448A (sh)
PE (1) PE110398A1 (sh)
PL (3) PL196069B1 (sh)
PT (1) PT831098E (sh)
RS (1) RS49598B (sh)
SI (1) SI0831098T1 (sh)
SV (1) SV1997000081A (sh)
TR (1) TR199900640T2 (sh)
TW (1) TW470746B (sh)
UA (1) UA59371C2 (sh)
WO (1) WO1998012199A1 (sh)
ZA (1) ZA978515B (sh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1313742A1 (en) * 2000-08-31 2003-05-28 Dr. Reddy's Laboratories Ltd. Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
US6740753B2 (en) * 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
CA2464306A1 (en) * 2001-10-29 2003-05-08 Dr. Reddy's Laboratories Ltd. Olanzapine dihydrate-ii a process for its preparation and use thereof
JP4530664B2 (ja) 2001-12-24 2010-08-25 サン・ファーマシューティカル・インダストリーズ・リミテッド ２−メチル−４−（４−メチル−１−ピペラジニル）−１０Ｈ−チエノ［２，３−ｂ］［１，５］ベンゾジアゼピンの結晶形Ｉ、この結晶形Ｉの製造方法、及び医薬組成物
WO2003091260A1 (en) * 2002-04-23 2003-11-06 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
SI1513846T1 (sl) * 2002-05-31 2011-11-30 Sandoz Ag Postopek za pripravo olanzapina form I
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
US7323459B2 (en) 2002-12-24 2008-01-29 Teva Pharmaceutical Industries Ltd. Crystal forms, methods for their preparation and method for preparation of olanzapine
EP1684734A2 (en) * 2003-11-18 2006-08-02 3M Innovative Properties Company Olanzapine containing transdermal drug delivery compositions
CN1906201A (zh) * 2003-12-22 2007-01-31 特瓦制药工业有限公司 合成奥氮平的方法
ATE504588T1 (de) 2004-01-27 2011-04-15 Synthon Bv Stabile salze von olanzapin
WO2005080401A1 (en) * 2004-02-19 2005-09-01 Neuland Laboratories Limited Process for the preparation of olanzapine form 1 useful as antipsychotic drug
ES2289974T1 (es) * 2004-07-14 2008-02-16 Shasun Chemicals And Drugs Limited Metodo mejorado para producir la forma i de la olanzapina.
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
WO2006027800A1 (en) * 2004-09-06 2006-03-16 Shasun Chemicals And Drugs Limited A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine
AU2005307797B2 (en) * 2004-11-16 2011-06-02 Alkermes Pharma Ireland Limited Injectable nanoparticulate olanzapine formulations
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
AU668159B2 (en) * 1992-05-29 1996-04-26 Lilly Industries Limited Pharmaceutical compounds
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
TR199900639T2 (xx) * 1996-09-23 1999-06-21 Eli Lilly And Company Olanzapin dihidrat D.

Also Published As

Publication number Publication date
EG23861A (en) 2007-11-18
EP0831098A3 (en) 1998-04-29
ZA978515B (en) 1999-03-23
IL128962A0 (en) 2000-02-17
RS49598B (sr) 2007-06-04
MY125565A (en) 2006-08-30
SI0831098T1 (en) 2002-04-30
HK1009807A1 (en) 1999-06-11
NO323980B1 (no) 2007-07-30
DE69708428T2 (de) 2002-07-04
CO4910140A1 (es) 2000-04-24
ATE209208T1 (de) 2001-12-15
DE69708428D1 (de) 2002-01-03
DK0831098T3 (da) 2002-05-21
PL332482A1 (en) 1999-09-13
HU226484B1 (en) 2009-03-02
IL128962A (en) 2003-01-12
EP0831098B1 (en) 2001-11-21
CA2265712A1 (en) 1998-03-26
CZ99099A3 (cs) 1999-11-17
ES2166051T3 (es) 2002-04-01
CN1122036C (zh) 2003-09-24
AR013838A1 (es) 2001-01-31
PL196069B1 (pl) 2007-12-31
TW470746B (en) 2002-01-01
PL196068B1 (pl) 2007-12-31
NO991382D0 (no) 1999-03-22
HUP0000066A2 (hu) 2000-06-28
NO991382L (no) 1999-03-22
KR100560015B1 (ko) 2006-03-15
EA199900326A1 (ru) 1999-08-26
JP2001500877A (ja) 2001-01-23
CZ299248B6 (cs) 2008-05-28
CN1234802A (zh) 1999-11-10
HUP0000066A3 (en) 2000-11-28
JP2009242407A (ja) 2009-10-22
BR9712100A (pt) 1999-08-31
PT831098E (pt) 2002-04-29
PL194565B1 (pl) 2007-06-29
EP0831098A2 (en) 1998-03-25
SV1997000081A (es) 1999-01-14
IN187156B (sh) 2002-02-16
UA59371C2 (uk) 2003-09-15
CA2265712C (en) 2006-10-31
PE110398A1 (es) 1999-01-14
TR199900640T2 (xx) 1999-06-21
NZ334448A (en) 2000-08-25
WO1998012199A1 (en) 1998-03-26
AU4484197A (en) 1998-04-14
US6020487A (en) 2000-02-01
ID27275A (id) 2001-03-22
KR20000048520A (ko) 2000-07-25
EA001642B1 (ru) 2001-06-25
AU719441B2 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
MY125565A (en) Intermediates and process for preparing olanzapine
MY125467A (en) Olanzapine dihydrate d
MX9800401A (es) Sistema transcorneal de liberacion de medicamentos.
MX214787B (es) Proceso de hidrogenacion.
ZA962342B (en) Process for preparing olanzapine.
IL118959A0 (en) Database apparatus
ZA971576B (en) Process for obtaining isophorone.
ZA97993B (en) Distillation process.
ZA97559B (en) Dihalopropene compounds, their use and intermediates for their production.
MY116503A (en) Process for preparing olanzapine
IL126989A (en) Process for making 4,6-dihydroxypyrimidine
HUP9904325A3 (en) Process for johexol manufacture
IL122454A (en) Process for forming bubble-pack
ZA985561B (en) Process for preparing 4-substituted-1H-Indole-3-Glyoxamides.
EP0682034A3 (en) Process for the preparation of cyanoalkylorganooxysilanes from cyanoalkylchlorosilanes.
EP0681995A3 (en) Method for inhibiting scaling.
ZA9710349B (en) Process for making benzisothiazolin-3-ones.
ZA975628B (en) Process for producing sourdough.
ZA9610458B (en) Novel method.
ZA9610053B (en) Process for preparing dioxoazabicyclohexanes.
ZA962851B (en) Process for vulcanization.
ZA971119B (en) Processes for preparing intermediates.
ZA971775B (en) Novel method.
ZA979066B (en) Process for the synthesis of β-ketonitriles.
GR1002949B (el) Φαρμακα